Megakaryopathia [Megacaryopathia; Megakaryo(Cit) + Greek. Pathos Suffering, Sick]

Megakaryopathy is a disorder of the hematopoietic system in which there is an abnormal increase in the number of megakaryocytes (cells that produce platelets). This condition can be caused by a variety of factors, such as genetic mutations, exposure to radiation or chemicals, and certain types of tumors.

Megakaryocytes play an important role in the blood clotting process as they produce platelets. When the number of these cells increases, platelet production occurs in excess, which can lead to blood clots and other serious diseases.

With megakaryopathy, various symptoms may occur, such as increased bleeding, frequent bleeding from the nose or gums, bruising of the skin and other signs of bleeding disorders. Symptoms associated with other diseases that are caused by excess platelet production may also occur.

Various tests are performed to diagnose megakaryopathies, including blood and bone marrow tests. Treatment may include medications that lower platelet levels in the blood, as well as surgical removal of tumors if they are the cause of the disease.

It is important to remember that megakariopathy is a serious condition that can lead to serious consequences if not treated promptly. Therefore, if you experience symptoms associated with a bleeding disorder, you should consult a doctor for diagnosis and treatment.

Megakaryocytes are large precursors of platelets. The gigantic size of megakaryocytes and a significant increase in the number of megakaryocytes in the myelogram indicate a general increase in myelopoiesis. The latter is always combined with an increase in the number of polymorphonuclear leukocytes (mainly